Search results
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoOSLO, Norway, June 4, 2024 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, today announces that it has commenced activities to support a new initiative ...
Drug-related infant deaths doubled between 2018 and 2022
UPI· 14 hours agoNew data finds that the rate of infants dying from drug-related reasons more than doubled between...
Novel Bispecific in EGFR-Mutant Lung Cancer Boosts PFS After Targeted Agents
MedPage Today· 5 days agoChina-based trial may present a hurdle to FDA approval, however
Medicare drug plans are slashing drug coverage — and it’s going to impact everyone
MarketWatch via Yahoo Finance· 7 days agoThe government’s Center for Medicare & Medicaid Services, which oversees the program...an exceptions...
Drinking water near Luke Air Force Base exceeded EPA's new PFAS levels in single-day tests
AZCentral | The Arizona Republic via Yahoo News· 2 days agoAs a result, humans have consumed these chemicals that have seeped into drinking and groundwater...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoU.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire TOKYO, May 30, 2024 If approved, the investigational ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 17 hours agoMitsubishi Tanabe Pharma America to Highlight Expansive ALS Research at the European Network to Cure ALS (ENCALS) 2024 Meeting PR Newswire JERSEY CITY, N.J., June 5, 2024 ...
In Baltimore’s Senior Homes, Overdoses Plague a Forgotten Generation
The New York Times via Yahoo News· 3 days agoBALTIMORE — Larnell Robinson sat at a desk in his cluttered office last September, between a...
Albert Einstein College of Medicine Names Marla Keller, M.D., Executive Dean
The Pilot News· 2 days agoMarla Keller, M.D., a national leader in academic medicine and in clinical and translational...
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on...
Morningstar· 5 days agoSeparate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset